Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
0.1454
-0.0346 (-19.22%)
At close: Feb 3, 2026, 4:00 PM EST
0.1474
+0.0020 (1.38%)
After-hours: Feb 3, 2026, 7:59 PM EST
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $8.1 million as of February 3, 2026. Its market cap has decreased by -89.30% in one year.
Market Cap
8.10M
Enterprise Value
-198.91K
1-Year Change
-89.30%
Ranking
Category
Stock Price
$0.15
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.58M to $8.10M, a decrease of -99.05%. That is a compound annual growth rate of -49.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 10.02M | -94.63% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioRestorative Therapies | 10.39M |
| GridAI Technologies | 10.25M |
| NuCana | 10.15M |
| CytoMed Therapeutics | 9.81M |
| Edesa Biotech | 9.79M |
| Chemomab Therapeutics | 9.73M |
| Ernexa Therapeutics | 9.66M |
| Pulmatrix | 9.64M |